According to Future Market Insights (FMI), the global mucosal atomization devices market was valued at US$ 460.4 Mn in 2021 and is predicted to reach US$ 837.7 Mn by 2029. The demand growth is majorly driven by superior efficiency and painless drug delivery nature of mucosal atomization devices, according to the report.
The market is still young, and FMI’s analysis expects a considerable increase in penetration rate over the course of coming years, in line with the thriving trends, such as non-invasive treatments and needleless drug delivery systems.
To learn more about this report: https://www.futuremarketinsights.com/reports/mucosal-atomization-devices-market
Developed regional markets are expected to hold prominent market share in terms of value. The market in Asia Pacific is also expected to grow at a significant rate. North America is expected to account for leading revenue shares in the mucosal atomization devices over the foreseeable future, predominantly attributing to the technological advancements in the field of healthcare.
The rate of adoption of drug delivery devices has been envisaged to remain high in Europe, which is driving the region’s mucosal atomization devices market. On the other side, the market in Asia Pacific is expected to grow at a significant growth rate as a result of the increasing frequency of new and efficient medical device launches.
Mucosal Atomization Devices Market Segmentation
The global market of mucosal atomization devices has been segmented on the basis of product type, technology, end user and regions such as North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East and Africa
By product type, nasal atomization devices are expected to hold prominent value shares of the global mucosal atomization devices market. Nasal passage is the most common route of administration, hence, nasal atomization devices are expected to show significant growth in the mucosal atomization devices market.
On the basis of technology, gas propelled atomization devices are expected to hold a large revenue share in the mucosal atomization devices market. Most of the key players operating in mucosal atomization devices market, are manufacturing gas propelled mucosal atomization devices.
Key Companies Profiled:
• Teleflex Incorporated
• DeVilbiss Healthcare LLC
• Cook Medical
• Medica Holdings, LLC.